INBRAIN Neuroelectronics
Developing high density and high resolution graphene intelligent neural systems for central and peripheral modulation. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€57—86m (Dealroom.co estimates Mar 2021.)
Company register number B67556670
Barcelona Catalonia (HQ)
Financials
Estimates*
EUR | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | <1m | <1m | <1m | <1m | <1m |
% growth | - | 79 % | 234 % | 60 % | 8 % |
EBITDA | - | (<1m) | (<1m) | - | - |
% EBITDA margin | - | (32 %) | (195 %) | - | - |
Profit | - | (<1m) | (<1m) | - | - |
% profit margin | - | (74 %) | (222 %) | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
€1.1m | Grant | ||
* | €2.5m | Grant | |
* | N/A | - | |
* | €3.0m | Convertible | |
* | €20.0m | Debt | |
Total Funding | €22.0m |
Related Content
Recent News about INBRAIN Neuroelectronics
EditMore about INBRAIN Neuroelectronics
EditOperator of a medical device company intended to provide high-density and resolution graphene intelligent neural systems. The company uses graphene to develop neural interfaces that can read and modulate brain activity at high resolution and detect therapy-specific biomarkers and trigger highly focal adaptive neuromodulation, helping patients to obtain optimal results in personalized neurological therapies.
Keywords: Pharmaceuticals and Biotechnology, Artificial Intelligence Technology, Bioelectronics Devices, Brain Computer Interface, Neural System, Neuro Sciences, Neuroelectronic Cell, Neurological Therapeutics, Neurological Therapy, Neurological Therapy Provider, Neurotechnology, Peripheral Nerve Modulation.
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.